• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Hermes Impact Opportunities Equity Fund Class F GBP Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Hermes Fund Managers Ireland Ltd
Fund Summary The investment objective of the Fund is to achieve long term capital appreciation by investing in companies which will benefit from meeting the worlds environmental and social challenges.
SEDOL code BD3FNV4
ISIN IE00BD3FNV41
Fund code HEIOA
Managers Martin Todd, Mark Sherlock
Manager Tenure 1 year
Morningstar Category Global Flex-Cap Equity
IMA Sector Global
Fund Size £179 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.95%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.0742
Buy Price £1.0742
Price Change +1.6177%
Price Date 3rd April 2020
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 3rd April 2018
Fund Status OPEN

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2019 2018
Fund Performance -1.66% +13.05%
Benchmark Performance
(Global Flex-Cap Equity)
+2.23%
Time Period Cumulative Benchmark Performance
(Global Flex-Cap Equity)
Fund Compared to Benchmark
1 day 1.62% -21.42% +23.04%
1 week -1.36% -17.87% +16.51%
1 month -14.85% -22.35% +7.50%
3 months -14.63% -17.73% +3.10%
6 months -8.42% -15.63% +7.22%
1 year -6.13% -8.42% +2.29%
3 years Currently unavailable Currently unavailable Currently unavailable
5 years Currently unavailable Currently unavailable Currently unavailable
10 years Currently unavailable Currently unavailable Currently unavailable
YTD -14.69% -3.10% -11.58%
Since inception 3.18% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Bank Rakyat Indonesia (Persero) Tbk Class B IDN 4.53%
Novo Nordisk A/S B DNK 4.34%
CSL Ltd AUS 4.32%
Umicore SA BEL 4.29%
Emergent BioSolutions Inc USA 4.26%
Ansys Inc USA 4.19%
Xylem Inc USA 4.13%
Abcam PLC GBR 4.10%
Agilent Technologies Inc USA 4.06%
Hannon Armstrong Sustainable Infrastructure Capital Inc USA 4.06%

Currently unavailable